North America Biomedical Refrigerators and Freezers Market size exceeded USD 1,420 million in 2021 and is anticipated to register a CAGR of 4% between 2022 and 2028.

Increasing investments in drug discovery over the last few years has fueled biomedical refrigerators and freezer sales in the US and Canada. The American Drug Society has been implementing supportive initiatives to support the R&D projects of drugmakers in the region. Private as well as government entities have been showing greater interest in investing toward the development of breakthrough treatments and therapies.

Get more details on this report - Request Free Sample PDF

Impact of COVID-19 on North America biomedical refrigerators and freezers market outlook

Although the COVID-19 pandemic initially had a negative impact on the market growth, fast-paced research activities encouraged industry players to ramp up their production rate to meet the spiraling equipment demand from research organizations.

During 2020, the U.S. Food and Drug Administration issued an emergency use authorization or EUA for using convalescent plasma to treat hospitalized COVID-19 patients. With ongoing clinical trials exploring the potential of plasma therapy for treating other life-threatening conditions, refrigerator and freezer use across clinical settings is growing.

North America Biomedical Refrigerators and Freezers Market, By End-use

The leading manufacturers of biomedical refrigerators and freezers in the region are upgrading their product portfolio to include advanced design features, including space and energy optimization. Major research institutes, hospitals, and blood banks are installing technologically upgraded refrigeration systems for preserving whole blood, platelets, plasma products, medical specimens, samples, drugs, and vaccines over extended periods of time.

Growing incidence of conditions such as hepatitis B and C as well as human immunodeficiency virus (HIV) is fueling biomedical refrigerators and freezers installation. Stringent regulations for conducting blood transfusion procedures will prompt blood centers and healthcare establishments to adopt more reliable medical refrigeration systems. As cancer is known to lower blood count by affecting certain organs including the spleen and the kidneys, a substantial number of cancer patients will continue to need blood transfusions.

North America Biomedical Refrigerators and Freezers Market, By Product

Canada plasma freezers industry share is expected to grow substantially through 2028, on account of the rising number of products acquiring approvals and certifications as standard equipment. According to the Canadian Blood Services, the national organization ensuring plasma sufficiency in the country, the demand for immune globulin (Ig) is among the highest among plasma protein products. Since the organization has been meeting only around 13-14% of the demand, it will adopt strategies to increase regional plasma collections, influencing the need for medical freezers.

Manufacturers are adding user-friendly temperature control and monitoring systems to ensure that temperature is consistent and easy to inspect. U.S. shock freezers industry share is set to expand at a steady pace by 2028, thanks to the rising number of product innovations. These medical grade-freezers are designed to maintain uniform temperature, at the same time safeguarding against unprecedented events such as power failures.

North America Market, By Country

U.S. biomedical refrigerators and freezers market will cross USD 1,770 million revenue by 2028. According to the Centers for Disease Control and Prevention (CDC), there are over 13.2 million blood donors, generating more than 17.2 million transfused blood product units every year in the country. Emergency treatment facilities and hospitals in the nation require blood transfusions for patients suffering from a host of chronic conditions and trauma injuries.

Numerous modern laboratories are focused on reducing their energy costs by embracing sustainable refrigeration. Units such as advanced ultra-low lab freezers consume nearly 25% less energy than standard freezers and are being installed in several facilities. Replacement of aging equipment across hospitals and diagnostic centers will enhance the sales of high-performance laboratory-grade biomedical freezers in the U.S.

Competitive Industry Landscape

Prominent participants operating across the North America biomedical refrigerators and freezers market include Follett, Panasonic Healthcare, Migali Scientific, Arctiko, B Medical, Azbil, Thermo Fisher Scientific, Helmer Scientific, Aegis Scientific, Powers Scientific, Liebherr International, Eppendorf, and Binder. Over the next few years, the industry participants in North America’s medical cold chain will continue to invest in R&D activities to launch innovative lab freezers & refrigerators, blood bank refrigerators, and ultra-low temperature freezers.